Does giving segmental muscle vibration alter the response to botulinum toxin injections in the treatment of spasticity in people with multiple sclerosis? A single-blind randomized controlled trial

Clinical Rehabilitation

Volumn 27, Issue 9, 2013, Pages 803-812

  Paoloni, Marco ^a   Giovannelli, Morena ^b   Mangone, Massimiliano ^a   Leonardi, Laura ^b   Tavernese, Emanuela ^a   Di Pangrazio, Elisabetta ^a   Bernetti, Andrea ^a   Santilli, Valter ^a   Pozzilli, Carlo ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

botulinum toxin; fatigue; Multiple sclerosis; spasticity; vibration

Indexed keywords

BOTULINUM TOXIN A; MUSCLE RELAXANT AGENT; BOTULINUM TOXIN;

COMPLICATION; CONTROLLED STUDY; DISABILITY; FATIGUE; FEMALE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MUSCLE SPASTICITY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; THERAPEUTIC USE; VIBRATION; ARTICLE; CONTROLLED CLINICAL TRIAL; SPASTICITY;

BOTULINUM TOXINS, TYPE A; DISABILITY EVALUATION; FATIGUE; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MUSCLE SPASTICITY; NEUROMUSCULAR AGENTS; SINGLE-BLIND METHOD; VIBRATION;

BOTULINUM TOXIN; FATIGUE; MULTIPLE SCLEROSIS; SPASTICITY; VIBRATION;

EID: 84881421609     PISSN: 02692155     EISSN: 14770873     Source Type: Journal    
DOI: 10.1177/0269215513480956     Document Type: Article

References (42)

1. Barnes MP, Kent RM, Semlyen JK, et al. Spasticity in multiple sclerosis. Neurorehabil Neural Repair. 2003 ; 17: 66-70
2. Rizzo MA, Hadjimichael OC, Preiningerova J, et al. Prevalence and treatment of spasticity reported by multiple sclerosis patients. Mult Scler. 2004 ; 10: 589-95
3. Balantrapu S, Sandroff BM, Sosnoff JJ, et al. Perceived impact of spasticity is associated with spatial and temporal parameters of gait in multiple sclerosis. ISRN Neurol. 2012 ;:
4. Sosnoff JJ, Gappmaier E, Frame A, et al. Influence of spasticity on mobility and balance in persons with multiple sclerosis. J Neurol Phys Ther. 2011 ; 35: 129-132
5. Hyman N, Barnes M, Bhakta B, et al. Botulinum toxin (Dysport) treatment of hip adduttor spasticity in multiple sclerosis: a prospective, randomised, double-blind, placebo controlled, dose ranging study. J Neurol Neurosurg Psychiatry. 2000 ; 68: 707-715
6. Giovannelli M, Borriello G, Castri P, et al. Early physiotherapy after injection of botulinum toxin increases the beneficial effects on spasticity in patients with multiple sclerosis. Clin Rehabil. 2007 ; 21: 331-337
7. Habek M, Karni A, Balash Y, et al. The place of the botulinum toxin in the management of multiple sclerosis. Clin Neurol Neurosurg. 2010 ; 112: 592-596
8. Varghese-Kroll E, Elovic EP. Contralateral weakness and fatigue after high-dose botulinum toxin injection for management of poststroke spasticity. Am J Phys Med Rehabil. 2009 ; 88: 495-499
9. Noma T, Matsumoto S, Etoh S, et al. Anti-spastic effects of the direct application of vibratory stimuli to the spastic muscles of hemiplegic limbs in post- stroke patients. Brain Inj. 2009 ; 23: 623-631
10. Roll JP, Vedel JP, Ribot E. Alteration of proprioceptive messages induced by tendon vibration in man: a microneurographic study. Exp Brain Res. 1989 ; 76: 213-222
11. Steyvers M, Levin O, Van Baelen M, et al. Corticospinal excitability changes following prolonged muscle tendon vibration. Neuroreport. 2003 ; 14: 1901-1905
12. Rosenkranz K, Rothwell JC. Differential effect of muscle vibration on intracortical inhibitory circuits in humans. J Physiol. 2003 ; 551: 649-660
13. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the «McDonald Criteria». Ann Neurol. 2005 ; 58: 840-846
14. Kurtzke J. Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1984 ; 33: 1444-1452
15. Bohannon RW, Smith MB. Inter-rater reliability on a modified Ashworth scale of muscle spasticity. Phys Ther. 1987 ; 67: 206-207
16. Krupp LB, LaRoca NG, Muir-Nash J, et al. The fatigue severity scale. Application to patients with multiple sclerosis and systematic lupos erythematosus. Arch Neurol. 1989 ; 46: 1121-1123
17. van der Putten JJ, Hobart JC, Freeman JA, et al. Measuring change in disability after inpatient rehabilitation: comparison of the responsiveness of the Barthel index and the Functional Independence Measure. J Neurol Neurosurg Psychiatry. 1999 ; 66: 480-484
18. Brown MC, Engberg I, Matthews PBC. The relative sensitivity to vibration of muscle receptors of the cat. J Physiol. 1967 ; 192: 773-800
19. Necking LE, Lundström R, Dahlin LB, et al. Tissue displacement is a causative factor in vibration- induced muscle injury. J Hand Surg. 1996 ; 21: 753-757
20. Hagbarth KE, Eklund G. The effects of muscle vibration in spasticity, rigidity, and cerebellar disorders. J Neurol Neurosurg Psychiatry. 1968 ; 31: 207-213
21. Santos-Filho SD, Cameron MH, Bernardo-Filho M. Benefits of whole-body vibration with an oscillating platform for people with multiple sclerosis: a systematic review. Mult Scler Int. 2012 ; 2012: 274728
22. Schyns F, Paul L, Finlay K, et al. Vibration therapy in multiple sclerosis: a pilot study exploring its effects on tone, muscle force, sensation and functional performance. Clin Rehabil. 2009 ; 23: 771-781
23. Schieppati M. The Hoffmann reflex: a means of assessing spinal reflex excitability and its descending control in man. Progr Neurobiol. 1987 ; 28: 345-376
24. Katz R. Presynaptic inhibition in humans: a comparison between normal and spastic patients. J Physiol Paris. 1999 ; 93: 379-385
25. Hagbarth KE, Wallin G, Lofstedt L. Muscle spindle responses to stretch in normal and spastic subjects. Scand J Rehabil Med. 1973 ; 5: 156-159
26. Noma T, Matsumoto S, Shimodozono M, et al. Anti-spastic effects of the direct application of vibratory stimuli to the spastic muscles of hemiplegic limbs in post-stroke patients: a proof-of-principle study. J Rehabil Med. 2012 ; 44: 325-330
27. McNulty PA, Jankelowitz SK, Wiendels TM, et al. Postactivation depression of the soleus H reflex measured using threshold tracking. J Neurophysiol. 2008 ; 100: 3275-3284
28. Murillo N, Kumru H, Vidal-Samso J, et al. Decrease of spasticity with muscle vibration in patients with spinal cord injury. Clin Neurophysiol. 2011 ; 122: 1183-1189
29. Siggelkow S, Kossev A, Schubert M, et al. Modulation of motor evoked potentials by muscle vibration: the role of vibration frequency. Muscle Nerve. 1999 ; 22: 1544-1548
30. Rosenkranz K, Pesenti A, Paulus W, et al. Focal reduction of intracortical inhibition in the motor cortex by selective proprioceptive stimulation. Exp Brain Res. 2003 ; 149: 9-16
31. Forner-Cordero A, Steyvers M, Levin O, et al. Changes in corticomotor excitability following prolonged muscle tendon vibration. Behav Brain Res. 2008 ; 190: 41-49
32. Marconi B, Filippi GM, Koch G, et al. Long-term effects on motor cortical excitability induced by repeated muscle vibration during contraction in healthy subjects. J Neurol Sci. 2008 ; 275: 51-59
33. Paoloni M, Mangone M, Scettri P, et al. Segmental muscle vibration improves walking in chronic stroke patients with foot drop: a randomized controlled trial. Neurorehabil Neural Repair. 2010 ; 24: 254-262
34. Palomar FJ, Mir P. Neurophysiological changes after intramuscular injection of botulinum toxin. Clin Neurophysiol. 2012 ; 123: 54-60
35. Frascarelli F, Di Rosa G, Bisozzi E, et al. Neurophysiological changes induced by the botulinum toxin type A injection in children with cerebral palsy. Eur J Paediatr Neurol. 2011 ; 15: 59-64
36. Currà A, Berardelli A. Do the unintended actions of botulinum toxin at distant sites have clinical implications?. Neurology. 2009 ; 72: 1095-1099
37. Currà A, Trompetto C, Abbruzzese G, et al. Central effects of botulinum toxin type A: evidence and supposition. Mov Disord. 2004 ; 19: S60-64
38. Lerdal A, Wahl A, Rustoen T, et al. Fatigue in the general population: a translation and test of the psychometric properties of the Norwegian version of the fatigue severity scale. Scand J Public Health. 2005 ; 33: 123-130
39. Tomasevic L, Zito G, Pasqualetti P, et al. Cortico-muscular coherence as an index of fatigue in multiple sclerosis. Mult Scler. 2013 ; 19 (3). 334-343
40. Nicholl L, Hobart J, Dunwoody L, et al. Measuring disability in multiple sclerosis: is the Community Dependency Index an improvement on the Barthel Index?. Mult Scler. 2004 ; 10: 447-450
41. Fleuren JF, Voerman GE, Erren-Wolters CV, et al. Stop using the Ashworth Scale for the assessment of spasticity. J Neurol Neurosurg Psychiatry. 2010 ; 81: 46-52
42. Rasova K, Martinkova P, Vyskotova J, et al. Assessment set for evaluation of clinical outcomes in multiple sclerosis: psychometric properties. Patient Relat Outcome Meas. 2012 ; 3: 59-70